BlueCrow Capital

Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Tonic App S.A. is a mobile application developer based in Porto, Portugal, founded in 2016. The company’s flagship application serves as a comprehensive platform for medical professionals, facilitating communication, collaboration, and information sharing among doctors. It enables users to message, share, and archive patient cases, seek expert advice, and network with peers. Tonic App is also utilized by hospitals, pharmaceutical and medical technology firms, as well as medical associations, to connect with healthcare professionals and disseminate relevant medical content. The application supports various functionalities including video consultations, clinical decision tools, and the sharing of medical images, thereby enhancing clinical work efficiency and improving patient outcomes. It is accredited as an e-library by the European Accreditation Council in CME, underscoring its commitment to quality and safety in clinical practices.

Ophiomics S.A. is a clinical-stage biotech company based in Lisbon, Portugal, focused on developing innovative diagnostic products and services for liver cancer. Established in 2015, Ophiomics integrates bioinformatics, genomics, and artificial intelligence to enhance the diagnostic and prognostic capabilities in oncology. The company specializes in creating biomarker-based diagnostic devices that utilize molecular signatures combined with clinical parameters in predictive algorithms, facilitating early detection of hepatocellular carcinoma. With a commitment to quality, Ophiomics holds ISO 13485 and ISO 9001 certifications and boasts a diverse pipeline of products at various stages of development, from pre-clinical programs to those undergoing clinical validation.